Surprising Benefits of Diabetes Drugs

Moderator(s)

• 

  Phyo Htoo, MD, PhD

  Instructor in Medicine
  Brigham and Women's Hospital and Harvard Medical School
  Boston, United States
• 

  Antonios Douros, MD (he/him/his)

  Associate Professor
  Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany, Germany

Presentations:

• 1:30 PM – 1:45 PM CEST

  Association between Metformin Use and Psychiatric Disorders in Patients with Diabetes
  

  Presenting Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University

  Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
• 1:45 PM – 2:00 PM CEST

  Effectiveness of metformin in preventing asthma exacerbations: a self-controlled case series and inverse propensity score weighting analysis
  

  Presenting Author: Bohee Lee, PharmD, PhD (she/her/hers) – Imperial College London

  Co-Author: Ernie Wong, PhD – Imperial College London

  Co-Author: Tricia Tan, PhD – Imperial College London

  Co-Author: Chloe Bloom, PhD – Imperial College London
• 2:00 PM – 2:15 PM CEST

  Using High Dimensional Iterative Causal Forest (hdiCF) to Identify Subgroups with Heterogeneous Treatment Effects: Glucagon-like Peptide 1 Receptor Agonists (GLP1RA) vs Sulfonylurea (SU) on Asthma Exacerbations
  

  Presenting Author: Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill

  Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill

  Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

  Co-Author: John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism

  Co-Author: Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics

  Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
• 2:15 PM – 2:30 PM CEST

  Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes
  

  Presenting Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

  Co-Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

  Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

  Co-Author: Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea

  Co-Author: Yoosoo Chang – Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea

  Co-Author: Seungho Ryu – Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea

  Co-Author: Christopher D Byrne – National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom

  Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
• 2:30 PM – 2:45 PM CEST

  Risk of kidney stones following SGLT2i- and GLP1-RA initiation among patients with type 2 diabetes in Denmark, Norway, UK, and Taiwan: Population-based active comparator, new user cohort studies and meta-analysis
  

  Co-Author: Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark

  Co-Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

  Co-Author: Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health

  Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Paz Lopez-Doriga Ruiz – Norwegian Institute of Public Health

  Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University

  Co-Author: Adrian Martinez de la Torre, PhD – Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich

  Co-Author: Andrea Michelle Burden, PhD – Swiss Fenderal Institute of Technology

  Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.

  Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University

  Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan

  Presenting Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
• 2:45 PM – 3:00 PM CEST

  Effect Modification by Hydroxychloroquine on the Nephrolithiasis Preventive Effect of SGLT2 Inhibitors
  

  Presenting Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Chan-Jung Liu – National Cheng Kung University Hospital

  Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan